CAS: 210826-40-7
Ref: IN-DA00BF68
| 2mg | 121.00 € | ||
| 5mg | 159.00 € | ||
| 10mg | 213.00 € | ||
| 50mg | 504.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 29 Apr 2025
N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
CAS:210826-40-7
Purity:
95+%
Molecular weight:
404.49g/mol
Ref: 54-OR97262
| 5mg | 129.00 € | ||
| 10mg | 209.00 € | ||
| 25mg | 477.00 € | ||
| 50mg | 809.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
Ref: 54-BUP05841
| 25mg | 248.00 € | ||
| 50mg | 384.00 € | ||
| 100mg | 589.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
MCC950
CAS:210826-40-7
CP-456773 (MCC950) inhibits NLRP3 inflammasome, prevents IL-1β secretion, and reduces multiple sclerosis model severity.
Formula:
C20H24N2O5S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
404.48
- Inhibitors
- Immunology and Inflammation
- NF-κB
- NOD
- See more categories
- Mcc950 and Impurities
Ref: TM-T3701
| 2mg | 35.00 € | ||
| 5mg | 55.00 € | ||
| 10mg | 87.00 € | ||
| 25mg | 159.00 € | ||
| 50mg | 253.00 € | ||
| 100mg | 394.00 € | ||
| 1mL*10mM (DMSO) | 60.00 € |
Estimated delivery in United States, on Monday 28 Apr 2025
N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-4-(2-hydroxypropan-2-yl)furan-2-sulfonamide
CAS:210826-40-7
Purity:
95.0%
Color and Shape:
Liquid, No data available.
Molecular weight:
404.4800109863281
Ref: 10-F545412
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 50mg | 732.00 € | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 7 May 2025
MCC-950
Controlled ProductCAS:210826-40-7
Formula:
C20H24N2O5S
Color and Shape:
Neat
Molecular weight:
404.48
Ref: TR-M199775
| 250mg | 9,788.00 € |
Estimated delivery in United States, on Tuesday 10 Jun 2025
